ID   HBDC
AC   CVCL_M273
SY   Hilar Bile Duct Carcinoma
DR   Wikidata; Q54881377
RX   CelloPub=CLPUB00275;
RX   PubMed=11180864;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 32.25 hours (PubMed=11180864).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=11180864; DOI=10.1007/s005340050211;
RA   Jiao W., Yakushiji H., Kitajima Y., Ogawa A., Miyazaki K.;
RT   "Establishment and characterization of human hilar bile duct carcinoma
RT   cell line and cell strain.";
RL   J. Hepatobiliary Pancreat. Surg. 7:417-425(2000).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//